Penumbra Inc
PEN- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001321732
No open-market purchases or sales by Penumbra Inc insiders were filed in the last 90 days; 452 institutions reported holding it in 13F filings for Q2 2026, worth $10.8B in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 9, 2026
- $12.7B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, −25 vs. previous quarter
- 452
- 13F valueReported value at the end of Q2 2026
- $10.8B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $1.40B
- +17.5% year over year
- Net income, FY2025
- $177.7M
- +1,168.1% year over year
- Free cash flow, FY2025
- $174.9M
- +18.8% year over year
- Revenue, Q3 FY2026
- $410.1M
- +15.6% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 15, 2026.
- Short interest
- 2.26M
- Shares sold short
- Change
- +16.9K
- +0.8% vs. previous
- Days to cover
- 6.76
- At average daily volume
Superinvestors holding PEN, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding PEN at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Penumbra Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 6, 2026 (view filing) | Apr 2 | 4 days | Grewal HarpreetDirector | SSale | −100 | $328.22 | −$32.8K | −1.1%8.72K after | 10b5-1 |
| Mar 4, 2026 (view filing) | Mar 2 | 2 days | Yuen MaggieChief Financial Officer | SSale | −2.43K | $342.30 | −$832.5K | −11.7%18.4K after | 10b5-1 |
| Jan 8, 2026 (view filing) | Jan 6 | 2 days | Grewal HarpreetDirector | SSale | −186 | $312.64 | −$58.2K | −2.2%8.23K after | 10b5-1 |
| Jan 6, 2026 (view filing) | Jan 2 | 4 days | Wilder ThomasDirector | SSale | −186 | $310.72 | −$57.8K | −100.0%0 after | 10b5-1 |
| Dec 15, 2025 (view filing) | Dec 11 | 4 days | Bose AraniDirector | SSale | −15.0K | $308.82 | −$4.63M | −5.5%258.5K after | 7 lots10b5-1 |
| Dec 9, 2025 (view filing) | Dec 5 | 4 days | Roberts JohannaEVP, Gen. Counsel & Secretary | SSale | −300 | $300.13 | −$90.0K | −0.5%63.8K after | 10b5-1 |
| Dec 3, 2025 (view filing) | Dec 1 | 2 days | Roberts JohannaEVP, Gen. Counsel & Secretary | SSale | −600 | $294.94 | −$177.0K | −0.9%64.1K after | 7 lots10b5-1 |
| Dec 3, 2025 (view filing) | Dec 2 | 1 day | Grewal HarpreetDirector | SSale | −100 | $292.98 | −$29.3K | −1.2%8.42K after | 10b5-1 |
| Nov 26, 2025 (view filing) | Nov 25 | 1 day | Roberts JohannaEVP, Gen. Counsel & Secretary | SSale | −1.80K | $300.06 | −$540.1K | −2.7%64.7K after | 10b5-1 |
| Nov 26, 2025 (view filing) | Nov 25 | 1 day | Bose AraniDirector | SSale | −7.50K | $300.19 | −$2.25M | −2.7%275.3K after | 10b5-1 |
Top 10 13F holders, Q2 2026
See all 452 holdersThe largest institutional positions in Penumbra Inc at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 4,297,555 | $1.36B | 0.02% | −32,901−0.8% | Reduced |
| HBK Investments L P | 1,838,508 | $580.5M | 6.75% | +204,247+12.5% | Added |
| Vanguard Capital Management LLC | 1,709,877 | $539.9M | 0.01% | +15,389+0.9% | Added |
| Vanguard Portfolio Management LLC | 1,667,276 | $526.4M | 0.02% | +12,799+0.8% | Added |
| State Street Corp | 1,243,258 | $392.6M | 0.01% | +57,447+4.8% | Added |
| ExodusPoint Capital Management, LP | 1,090,430 | $344.3M | 3.19% | +625,215+134.4% | Added |
| Balyasny Asset Management LLC | 1,090,163 | $344.2M | 0.63% | +328,067+43.0% | Added |
| JPMorgan Chase & Co | 1,071,454 | $338.6M | 0.02% | +668,835+166.1% | Added |
| Goldman Sachs Group Inc | 847,104 | $267.5M | 0.03% | +126,529+17.6% | Added |
| Arrowstreet Capital, Limited Partnership | 834,903 | $263.6M | 0.12% | +434,743+108.6% | Added |
Holders of 5% or more of PEN
See all 1 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Penumbra Inc.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| Vanguard Capital Management LLC | 13G | 5.07%1.99M shares | New | Apr 30, 20261 filing | Apr 30, 2026 | SEC |
Politician trades
All politician trades in PEN1 member of Congress reported 1 trade in Penumbra Inc since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Aug 13, 2025 |  Lisa C. McClain House · MI | Sell | $1K-$15K |
House · MI · Aug 13, 2025
Sell$1K-$15K